相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmaceutical Amorphous Nanoparticles
Rajan Jog et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Complexation of Polyelectrolytes with Hydrophobic Drug Molecules in Salt-Free Solution: Theory and Simulations
Qun-li Lei et al.
LANGMUIR (2017)
Amorphous nanoparticle complex of perphenazine and dextran sulfate as a new solubility enhancement strategy of antipsychotic perphenazine
Bingxue Dong et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2017)
A supersaturating delivery system of silibinin exhibiting high payload achieved by amorphous nano-complexation with chitosan
Minh-Hiep Nguyen et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Investigation of a suitable in vitro dissolution test for itraconazole-based solid dispersions
Justine Thiry et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Dual drug-loaded biofunctionalized amphiphilic chitosan nanoparticles: Enhanced synergy between cisplatin and demethoxycurcumin against multidrug-resistant stem-like lung cancer cells
Wei-Ting Huang et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2016)
Co amorphous systems: A product development perspective
Rahul B. Chavan et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Effect of Compression on the Molecular Arrangement of Itraconazole-Soluplus Solid Dispersions: Induction of Liquid Crystals or Exacerbation of Phase Separation?
Abhishek Singh et al.
MOLECULAR PHARMACEUTICS (2016)
Cost-effective alternative to nano-encapsulation: Amorphous curcumin-chitosan nanoparticle complex exhibiting high payload and supersaturation generation
Minh Hiep Nguyen et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
Dissolution performance of binary amorphous drug combinations-Impact of a second drug on the maximum achievable supersaturation
Niraj S. Trasi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Development of hot melt co-formulated antimalarial solid dispersion system in fixed dose form (ARLUMELT): Evaluating amorphous state and in vivo performance
Ritesh Fule et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Thermodynamics of Highly Supersaturated Aqueous Solutions of Poorly Water-Soluble DrugsImpact of a Second Drug on the Solution Phase Behavior and Implications for Combination Products
Niraj S. Trasi et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Development of Sustained Release NanoFDC (Fixed Dose Combination) for Hypertension - An Experimental Study
Anjuman Arora et al.
PLOS ONE (2015)
Preparation and characterization of co-amorphous Ritonavir-Indomethacin systems by solvent evaporation technique: Improved dissolution behavior and physical stability without evidence of intermolecular interactions
Swapnil J. Dengale et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Amorphization Strategy Affects the Stability and Supersaturation Profile of Amorphous Drug Nanoparticles
Wean Sin Cheow et al.
MOLECULAR PHARMACEUTICS (2014)
Pooled safety analysis of the fixed-dose combination of indacaterol and glycopyrronium (QVA149), its monocomponents, and tiotropium versus placebo in COPD patients
Jadwiga A. Wedzicha et al.
RESPIRATORY MEDICINE (2014)
A novel curcumin-artemisinin coamorphous solid: physical properties and pharmacokinetic profile
Kuthuru Suresh et al.
RSC ADVANCES (2014)
Emerging trends in the stabilization of amorphous drugs
Riikka Laitinen et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Green preparation of antibiotic nanoparticle complex as potential anti-biofilm therapeutics via self-assembly amphiphile-polyelectrolyte complexation with dextran sulfate
Wean Sin Cheow et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2012)
Flocculated amorphous itraconazole nanoparticles for enhanced in vitro supersaturation and in vivo bioavailability
Maria A. Miller et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2012)
Self-assembled amorphous drug-polyelectrolyte nanoparticle complex with enhanced dissolution rate and saturation solubility
Wean Sin Cheow et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2012)
A systematic review of adherence, treatment satisfaction and costs, in fixed-dose combination regimens in type 2 diabetes
Valerie Hutchins et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: Basic approaches and practical applications
Yohei Kawabata et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility
Dongsheng Mou et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
Evidence for promoting fixed-dose combination drugs in tuberculosis treatment and control: a review
I. Monedero et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2011)
Compliance, Safety, and Effectiveness of Fixed-Dose Combinations of Antihypertensive Agents A Meta-Analysis
Ajay K. Gupta et al.
HYPERTENSION (2010)
Understanding the Behavior of Amorphous Pharmaceutical Systems during Dissolution
David E. Alonzo et al.
PHARMACEUTICAL RESEARCH (2010)
Combinatorial Drug Conjugation Enables Nanoparticle Dual-Drug Delivery
Santosh Aryal et al.
SMALL (2010)
Preparation of amorphous cefuroxime axetil nanoparticles by sonoprecipitation for enhancement of bioavailability
Ravindra S. Dhumal et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2008)
Impact of fixed-dose combination drugs on adherence to prescription medications
Feng Pan et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2008)
The impact of medication regimen factors on adherence to chronic treatment: a review of literature
Karen S. Ingersoll et al.
JOURNAL OF BEHAVIORAL MEDICINE (2008)
Design of potent amorphous drug nanoparticles for rapid generation of highly supersaturated media
Michal E. Matteucci et al.
MOLECULAR PHARMACEUTICS (2007)
Fixed-dose combinations improve medication compliance: A meta-analysis
Sripal Bangalore et al.
AMERICAN JOURNAL OF MEDICINE (2007)
Amorphous drug nanosuspensions. 1. Inhibition of Ostwald ripening
L Lindfors et al.
LANGMUIR (2006)
Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon:: open-label multicentre trial
C Laurent et al.
LANCET (2004)
In vitro activity of amphotericin B and itraconazole in combination with flucytosine, sulfadiazine and quinolones against Exophiala spinifera
RG Vitale et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Combined budesonide and antibiotic therapy for active Crohn's disease: a randomized controlled trial
AH Steinhart et al.
GASTROENTEROLOGY (2002)
Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide
M Skov et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
分享论文
